Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

At Berlin's Charité: First regular treatment with gene scissors in Germany

The Nobel Prize was awarded in 2020 for the development of the Crispr method. Now, a patient has received a corresponding medication nationwide for the first time since the approval of the gene scissors therapy.

Translated from German Read in German

At Berlin's Charité: First regular treatment with gene scissors in Germany

A 19-year-old patient, Mohammed, has been successfully treated with a gene therapy based on the CRISPR gene editing tool at Charité in Germany. Mohammed suffers from beta-thalassemia, a genetic blood disorder, and no longer requires blood transfusions after the treatment with the medication "Casgevy". The therapy, developed by Emmanuelle Charpentier and Jennifer Doudna, who received the Nobel Prize in 2020, involves editing genes in bone marrow stem cells to produce functional hemoglobin.

The treatment was administered to Mohammed in May 2026 and he has since shown significant improvement, including a regenerated immune system.

Written by urgent.news from Handelsblatt's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.

Read the original at handelsblatt.com →

More in Health & Medicine

More from Tuesday 6 October →